Just out today is a podcast interview for Smart Drug Smarts between host Jesse Lawler and interviewee Brian D. Earp on “The Medicalization of Love” (title taken from a recent paper with Anders Sandberg and Julian Savulescu, available from the Cambridge Quarterly of Healthcare Ethics, here).
Below is the abstract and link to the interview:
What is love? A loaded question with the potential to lead us down multiple rabbit holes (and, if you grew up in the 90s, evoke memories of the Haddaway song). In episode #95, Jesse welcomes Brian D. Earp on board for a thought-provoking conversation about the possibilities and ethics of making biochemical tweaks to this most celebrated of human emotions. With a topic like “manipulating love,” the discussion moves between the realms of neuroscience, psychology and transhumanist philosophy.
Earp, B. D., Sandberg, A., & Savulescu, J. (2015). The medicalization of love. Cambridge Quarterly of Healthcare Ethics, Vol. 24, No. 3, 323–336.
Guest Post: Pervitin instead of coffee? Change in attitudes to cognitive enhancement in the 50’s and 60’s in Brazil
Written by Marcelo de Araujo
State University of Rio de Janeiro
CNPq – The Brazilian National Council for Scientific and Technological Development
How does our attitude to drugs in general shape our reaction to “smart drugs” in particular? Ruairidh Battleday and Anna-Katharine Brem have recently published a systematic review of 24 studies on the effect of modafinil on healthy individuals. They concluded that “modafinil may well deserve the title of the first well-validated pharmaceutical ‘nootropic’ agent.” This publication has rekindled the debate on the ethics of “smart drugs”. Of course further studies are necessary for a better assessment of the safety and efficacy of modafinil. But if modafinil, or some other drug, proves safe and effective in the future, are there reasons to oppose its widespread use in society?
Written by Anke Snoek
When neuroscience started to mingle into the debate on addiction and self-control, people aimed to use these insights to cause a paradigm shift in how we judge people struggling with addictions. People with addictions are not morally despicable or weak-willed, they end up addicted because drugs influence the brain in a certain way. Anyone with a brain can become addicted, regardless their morals. The hope was that this realisation would reduce the stigma that surrounds addiction. Unfortunately, the hoped for paradigm shift didn’t really happen, because most people interpreted this message as: people with addictions have deviant brains, and this view provides a reason to stigmatise them in a different way. Continue reading
Written by Anke Snoek
Many of us experience failure of self-control once in a while. These failures are often harmless, and may involve alcohol or food. Because we have experiences with these failures of self-control, we think that something similar is going on in cases of addiction or when people who can’t control their eating on a regular basis. Because we fail to exercise willpower once in a while over food or alcohol, we think that people who regularly fail to control their eating or substance use, must be weak-willed. Just control yourself. Continue reading
A recent series of papers have constructed a biochemical pathway that allows yeast to produce opiates. It is not quite a sugar-to-heroin home brew yet, but putting together the pieces looks fairly doable in the very near term. I think I called the news almost exactly five years ago on this blog.
People, including the involved researchers, are concerned and think regulation is needed. It is an interesting case of dual-use biotechnology. While making opiates may be somewhat less frightening than making pathogens, it is still a problematic use of biotechnology: millions of people are addicted, and making it easier for them to get access would worsen the problem. Or would it?
In a fascinating paper presented at the St Cross Ethics Seminar in Oxford, on 27 March 2014, Professor Neil Levy (Oxford and Melbourne) sought to solve the following puzzle about addicts: on the one hand, addicts are thought to lack control, but on the other they appear to engage in the kind of reason-responsive behaviour typical of rational agents (for example, many addicts for a small financial incentive will avoid the objects to which they are addicted).
Levy’s central claim was that addicts do lack control, but that this lack of control consists in a lack of control over belief-formation, leading to a change of mind – or ‘judgement-shift’. So addicts are rational in so far as they are acting on the basis of their current beliefs about what is best for them. Continue reading
The death of celebrities due to addiction: on helpful and unhelpful distinctions in destigmatising addiction
Philip Seymour Hoffman is dead. Probably due to an overdose of heroin. Hoffman didn’t have to die if he wasn’t so ashamed of his substance use that he did it in secrecy. Because he overdosed alone, no one could call an ambulance on him that would have probably saved his life. http://truth-out.org/news/item/21645-philip-seymour-hoffman-didnt-have-to-die#.UvAI48u3dcc.facebook Some are using the media attention surrounding his death to push for better drug laws. Some want to treat heroin addicts with heroin while some simply want to draw attention to a secret demographic: high educated, rich, white, middle age heroin users. Both attempts try to destigmatise heroin use. Continue reading
For years, ‘sin taxes’ – taxes on socially undesirable and/or addictive substances/activities like smoking, alcohol and gambling – have been a source of controversy. On the one hand, they have been seen as an effective means to raise revenue and reduce consumption of addictive (and generally unhealthy) substances. On the other hand, sin taxes are generally regressive and are rather paternalistic. But beyond these typical disputes, recent research has found a new and important dimension to the sin tax debate: genetics. A study by Jason Fletcher has found that whether or not taxes reduce cigarette consumption depends on the presence of a particular genotype. This suggests an interesting and novel policy: only apply the cigarette tax to those whose genotype indicates they will respond to the tax. But is this a sound policy, or should we be keeping biomarkers out of policy debates over sin taxes? Continue reading
By Julian Savulescu and Bennett Foddy
Former Brazilian President, Fernando Henrique Cardoso, has argued that the war on drugs has failed and cannabis should be decriminalised. He argued that the hardline approach has brought “disastrous” consequences for Latin America. Having just returned from Rio, one can only agree. One of us was staying with an eminent professor of philosophy. We were returning to her house with her 11 year old daughter, only to have our way blocked by police with machine guns. They were hunting a drug lord in the local favela – this road was the only escape route and they were preparing for possible altercation.
Cardoso highlights the practical failure of a zero-tolerance approach. A zero tolerance approach to a crime like taking drugs must always fail, in the same way as a zero-tolerance approach to alcohol, prostitution or drugs in sport will always fail. Paradoxically, the worst thing you could do to the drug lords in Rio is not to wage a war on them, but to decriminalise cocaine and marijuana. They would be out of business in one day. Supplies could be monitored, controlled and regulated – the harm to users and third parties significantly reduced.
The case for legalizing drugs has been made often, most recently by Cardoso and by Australia’s foreign minister, Bob Carr, who this week co-signed a report declaring that ‘the war on drugs has failed’. The argument is nearly always put forward in terms of the burdens that the drug war has imposed on us in terms of crime and public health. And it is true that these things give us good reason to abandon Nixon’s war on drugs. But we so rarely hear a moral argument in favour of liberalizing drug laws. This is a mistake. Although experts have told us time and time again that things would be better without the drug war, politicians have ignored the expert advice because voters do not want drugs laws to be loosened. And voters feel this way not because they think they know better than the experts, but because they have moral objections to drug use. There is a hidden moral debate driving the war on drugs that we never seem to bring out in the open.
By Brian Earp
Forget about “medical marijuana.” Isn’t it time to legalize heroin in the United States? Recreational cocaine? Ecstasy? LSD? How about the whole nefarious basketful of so-called ‘harder’ drugs?
Yes, it is, says Dr. Ron Paul, a fourteen-term libertarian congressman and obstetrician from the state of Texas. It’s a view shared by virtually none of his Republican colleagues, nor, for that matter, very many Democrats. Nor really anyone in the “mainstream” of American politics. But in this post, I’ll argue that he’s right.
Paul—who is currently making his third bid for President of the United States, and polling third among Republican contenders—offered his perspective to comedian and Daily Show host Jon Stewart in an interview earlier this week: